Monday, 27 May 2019

Shares Of Lupin Declined 5.5 Percent In The Early Trade On Monday

Shares of Lupin declined 5.5 percent in the early trade on Monday after USFDA classified the inspection as official action indicated.

The company has received a communication from the USFDA classifying the inspection conducted at its Goa facility between January 28 to February 8, 2019 as OAI, company said in release.

Glenmark Pharmaceuticals receives ANDA approval for Aspirin and extended-release Dipyridamole capsules, 25 mg/200 mg.

For more information ✆ +91- 6232578593 or visit www.moneymarketmanthan.com
-
Labels: , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Trends On SGX Nifty Indicate A Positive Opening For The Broader Index In India

Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 31.5 points gain or 0.25 percent. The Nifty future...